Elevated Adipocyte Membrane Phospholipid Saturation Does Not Compromise Insulin Signaling.

Publication Year: 2023

DOI:
10.2337/db22-0293

PMCID:
PMC10545576

PMID:
36580483

Journal Information

Full Title: Diabetes

Abbreviation: Diabetes

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"metabolomics data are deposited at european molecular biology laboratory-european bioinformatics institute (embl-ebi) metabolights ( ) with identifier mtbls6080 and can be accessed here: https://www ebi ac uk/metabolights/mtbls6080 ."

Code Sharing
Evidence found in paper:

"Duality of Interest. H.P., K.P., S.B., A.A., R.N., L.L., M.G., A.-C.A., L.A., C.B., M.K., B.K., S.W., D.K., S.H., M.M., M.B.-Y., and X.-R.P. are presently employed by AstraZeneca and may be AstraZeneca shareholders. No other potential conflicts of interest relevant to this article were reported."

Evidence found in paper:

"Funding. NanoSIMS data were obtained at the Chemical Imaging Infrastructure, joint infrastructure of Chalmers University of Technology and University of Gothenburg, supported by the Knut and Alice Wallenberg Foundation and hosted by the AstraZeneca BioVentureHub. This project has received funding from Stiftelsen för Strategisk Forskning (ID16-0049). C.B. is supported by Stiftelsen för Strategisk Forskning (ID18-0082)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025